Market Updates

Provexis Enters Into Exclusivity Agreement

Provexis Enters Into Exclusivity Agreement
Provexis, London, U.K., has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow heart-health technology. Under the terms of the agreement, Provexis and its partner will develop a second-generation concentrated format of the Fruitflow product. The new format will increase its applicability across all food, beverage, supplement and medical formats.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters